Fundraising Fox티씨노바이오사이언스
2 known investors
Find your way into 티씨노바이오사이언스
Sign up to see every warm intro you have to 티씨노바이오사이언스
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 티씨노바이오사이언스 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TXINNO is a biotech company developing small-molecule innovative anticancer drugs, with a scientific focus on the innate immune system and RAS signaling pathways. Its work spans drug discovery platforms and a therapeutic pipeline aimed at treating cancer patients.
Founders & leadership
Investors · 2
Frequently asked questions
- What does 티씨노바이오사이언스 do?
- TXINNO is a biotech company developing small-molecule innovative anticancer drugs, with a scientific focus on the innate immune system and RAS signaling pathways. Its work spans drug discovery platforms and a therapeutic pipeline aimed at treating cancer patients.
- Who are 티씨노바이오사이언스's investors?
- 티씨노바이오사이언스's investors include Schmidt, Solidus Investment.